“Tozaride: Targeted & Personalized Treatment for Small Cell Lung and Neuroendocrine Cancer”

In Clinical Development, Featured on App, Orphan Drug Congress by Freya SmaleLeave a Comment

Chris Adams of Andarix Pharmaceuticals joined us for World Orphan Drug Congress USA 2015 to present about ‘ Tozaride: Targeted & Personalized Therapy for Small Cell Lung and Neuroendocrine Cancer’ 
Download his presentation now to understand more about:

  • Receptor-targeted therapy 
  • Tozaride Key Properties
  • Vixilide–Clinical Data

…and much more! 

Get your copy here!  

To find out more about  personalized therapy for small cell lung and neuroendocrine cancer , attend  World Orphan Drug Congress USA 2016 April 20-22  in Washington, DC.

Leave a Comment